About
Mohammad E. Sayed is a translational scientist working in cell and gene therapy, CMC, and platform development. Public materials indicate he has been associated with Telos Biotech, including as a co-founder and chief scientific officer, and his earlier academic work includes telomerase and cancer-biology research connected to UT Southwestern. He appears to be a biotech operator/scientist rather than a fund manager or capital allocator.
Areas of interest
biotechcell therapygene therapyCMCplatform developmenttranslational sciencecancer biologytelomerase research